Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion description "[(5) Vioxx also enhanced expression of COX-2, PPARy, Bax, and caspase-3, while inhibiting the expression of Bcl-2 and survivin, suggesting that COX-2 blockade might be useful in chemoprevention against gastric cancer possibly due to enhancement of the PPARy- and proapoptotic proteins-dependent apoptosis and the reduction in progastrin/gastrin-induced promotion of tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion evidence source_evidence_literature NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion SIO_000772 14627349 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion wasDerivedFrom befree-2016 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion wasGeneratedBy ECO_0000203 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- befree-2016 importedOn "2016-02-19" NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.